A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1
NCT06191354
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Spinal Muscular Atrophy 1
Interventions
GENETIC:
SKG0201 Injection
Sponsor
Kun Sun